Literature DB >> 478692

Selective cytotoxicity of tunicamycin for transformed cells.

K Olden, R M Pratt, K M Yamada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 478692     DOI： 10.1002/ijc.2910240111

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  6 in total

1.  Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells.

Authors:  M J Humphries; K Matsumoto; S L White; K Olden
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

2.  Ultrastructural alterations in human lymphoblastoid B cell lines treated with tunicamycin.

Authors:  M C Glassy; S Ferrone
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

3.  Response of malignant and nonmalignant epidermal cell lines to tunicamycin.

Authors:  M M Brysk; J Miller; S J Chen; P C Moller; R W Stach
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

4.  Inhibition of the formation of lipid-linked intermediates in normal and transformed cells by a purified tunicamycin homologue.

Authors:  R Eren; D Duksin
Journal:  Mol Cell Biochem       Date:  1985-05       Impact factor: 3.396

5.  Carbohydrate requirement for expression and stability of acetylcholine receptor on the surface of embryonic muscle cells in culture.

Authors:  J M Prives; K Olden
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Inhibition of fusion of embryonic muscle cells in culture by tunicamycin is prevented by leupeptin.

Authors:  K Olden; J Law; V A Hunter; R Romain; J B Parent
Journal:  J Cell Biol       Date:  1981-01       Impact factor: 10.539
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.